1 | Busulfan, Cyclophosphamide, Antithymocyte Globulin | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 20 💬
|
2 | Busulfan, Cyclophosphamide, ATG | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 19 19 💬
|
3 | Busulfan, Cyclophosphamide, ATG, GCSF | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
4 | Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen) | [4] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Busulfan, Cyclophosphamide, Fludarabine | [4] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 326 326 💬
|
5 | Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine. | [4] Busulfan Busulfan, Cyclophosphamide, Cyclosporine, Fludarabine | [5] Cyclosporine
Cyclosporine
,
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [6] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬
| [39] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 285 💬
|
6 | Campath, Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 💬
|
7 | Cyclophosphamid | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 66 66 💬
|
8 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
|
9 | Cyclophosphamide (CY) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
10 | Cyclophosphamide (CY) (Plan 1) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 60 60, 285 💬
|
11 | Cyclophosphamide (CY) (Plan 2) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 60 60, 285 💬
|
12 | Cyclophosphamide (Cytoxan) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
13 | Cyclophosphamide (drug) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
14 | Cyclophosphamide + pred | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 283 283 💬
|
15 | Cyclophosphamide 100mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
16 | Cyclophosphamide 150mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
17 | Cyclophosphamide 30 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 65 65, 285, 326 💬
|
18 | Cyclophosphamide 40 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 65 65, 285, 326 💬
|
19 | Cyclophosphamide 50mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
20 | Cyclophosphamide 50Mg Oral Tablet | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 162 162 💬
|
21 | Cyclophosphamide and ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
22 | Cyclophosphamide and fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 11 11, 13 💬
|
23 | Cyclophosphamide and steroids | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 222 222 💬
|
24 | Cyclophosphamide Dose Level 1 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
25 | Cyclophosphamide Dose Level 2 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
26 | Cyclophosphamide Dose Level 3 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
27 | Cyclophosphamide Dose Level 4 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
28 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | [3] Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Cyclophosphamide
,
Cyclophosphamide
💬
| [2] DHFR DHFR, DHFR2 💬
| [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 💬
|
29 | Cyclophosphamide Injection 1g | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 50 50, 51, 52 💬
|
30 | CYCLOPHOSPHAMIDE MONOHYDRATE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [4] 13 13, 60, 96, 256 💬
|
31 | Cyclophosphamide post transplant | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
32 | Cyclophosphamide(CTX) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 224 224 💬
|
33 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | [4] Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone, Prednisone | [5] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Methylprednisolone
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
34 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
35 | Cyclophosphamide, Bortezomib, dexamethasone | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
36 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | [4] Bortezomib Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone | [5] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
,
Daratumumab
💬
| [3] CD38 CD38, NR3C1, PSMB5 💬
| [16] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
37 | Cyclophosphamide, fludarabine , thymoglobulin | [3] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
38 | Cyclophosphamide, Fludarabine, Rabbit ATG | [4] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine, Rabbit | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
39 | Cyclophosphamide, Fludarabine, Thymoglobulin | [3] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
40 | Cyclophosphamide,Campath IH and TBI | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
41 | Cyclophosphamide,cyclosporine A | [2] Cyclophosphamide Cyclophosphamide, Cyclosporine | [3] Cyclosporine
Cyclosporine
,
Cyclophosphamide
,
Cyclophosphamide
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
42 | Cyclophosphamide-prednisone-azathioprine | [3] Azathioprine Azathioprine, Cyclophosphamide, Prednisone | [4] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
43 | Cyclophosphamide/ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
44 | Cyclophosphamide/Glatiramer acetate | [3] Acetate Acetate, Cyclophosphamide, Glatiramer | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
45 | Cyclophosphamide/Rituximab | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
46 | Cyclophosphamidum | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 44 44 💬
|
47 | Cyclophosphamidum 500 mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 44 44 💬
|
48 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | [4] Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate | [4] Methotrexate
Methotrexate
,
Cyclophosphamide
,
Doxorubicin
,
Cyclophosphamide
💬
| [4] DHFR DHFR, DHFR2, TOP2A, TOP2B 💬
| [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | [1] 65 65 💬
|
49 | Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [3] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
50 | Glucocorticoid combined with cyclophosphamide induction + maintenance | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 222 222 💬
|
51 | Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide'' | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
52 | High-dose Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 96 96 💬
|
53 | IV Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 51 51 💬
|
54 | Lenalidomide, Dexamethasone and Cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Dexamethasone, Lenalidomide | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Lenalidomide
,
Cyclophosphamide
💬
| [2] NR3C1 NR3C1, TNF 💬
| [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 28 28 💬
|
55 | Prednisone and cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
56 | Prednisone plus cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
57 | Prednisone, cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 40 40 💬
|
58 | Prednisone, methylprednisolone,cyclophosphamides | [2] Methylprednisolone Methylprednisolone, Prednisone | [2] Methylprednisolone
Methylprednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
59 | Rituximab and Cyclophosphamide IV | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 35 35 💬
|
60 | Rituximab, Cyclophosphamide, and Corticosteroids | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 💬
|
61 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
,
Cyclophosphamide
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
62 | Thalidomide, cyclophosphamide and prednisone | [3] Cyclophosphamide Cyclophosphamide, Prednisone, Thalidomide | [4] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Thalidomide
,
Cyclophosphamide
💬
| [2] NR3C1 NR3C1, TNF 💬
| [68] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 331 331 💬
|